Figure 2.

Proportions of patients in the Diabetes Monitoring Database (DIAMOND) and Joint Asia Diabetes Evaluation (JADE) groups attaining treatment targets at repeat assessment after 1 year of follow‐up. Between‐group comparisons adjusted for trial centre, age, gender, disease duration and baseline value. All P‐values for within‐group comparison (CA2 vs baseline) were P < 0.01 except that of JADE on blood pressure (BP) < 130/80 mmHg (P = 0.239). No significant difference for changes in target achievement between groups. Only patients with paired data for baseline and second comprehensive assessment (CA2) are included in analysis. SMBG, self‐monitoring of blood glucose.